211 related articles for article (PubMed ID: 32486284)
21. Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.
Bheda A; Shackelford J; Pagano JS
PLoS One; 2009 Aug; 4(8):e6764. PubMed ID: 19707515
[TBL] [Abstract][Full Text] [Related]
22. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
[TBL] [Abstract][Full Text] [Related]
23. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
[TBL] [Abstract][Full Text] [Related]
24. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
Dang LC; Melandri FD; Stein RL
Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
[TBL] [Abstract][Full Text] [Related]
25. The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons.
Bishop P; Rubin P; Thomson AR; Rocca D; Henley JM
J Biol Chem; 2014 Dec; 289(52):36140-9. PubMed ID: 25326379
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E
PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658
[TBL] [Abstract][Full Text] [Related]
27. Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Puri S; Hsu SD
Biochem Biophys Res Commun; 2022 Apr; 599():57-62. PubMed ID: 35176625
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction.
Chen F; Sugiura Y; Myers KG; Liu Y; Lin W
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1636-41. PubMed ID: 20080621
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
30. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S
Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731
[TBL] [Abstract][Full Text] [Related]
31. Activity-Based Proteomic Profiling of Deubiquitinating Enzymes in Salmonella-Infected Macrophages Leads to Identification of Putative Function of UCH-L5 in Inflammasome Regulation.
Kummari E; Alugubelly N; Hsu CY; Dong B; Nanduri B; Edelmann MJ
PLoS One; 2015; 10(8):e0135531. PubMed ID: 26267804
[TBL] [Abstract][Full Text] [Related]
32. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
33. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
34. Multiple ubiquitin C-terminal hydrolases from chick skeletal muscle.
Woo SK; Lee JI; Park IK; Yoo YJ; Cho CM; Kang MS; Ha DB; Tanaka K; Chung CH
J Biol Chem; 1995 Aug; 270(32):18766-73. PubMed ID: 7642526
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin C-terminal hydrolase-activity is involved in sperm acrosomal function and anti-polyspermy defense during porcine fertilization.
Yi YJ; Manandhar G; Sutovsky M; Li R; Jonáková V; Oko R; Park CS; Prather RS; Sutovsky P
Biol Reprod; 2007 Nov; 77(5):780-93. PubMed ID: 17671268
[TBL] [Abstract][Full Text] [Related]
37. Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.
Kurihara LJ; Kikuchi T; Wada K; Tilghman SM
Hum Mol Genet; 2001 Sep; 10(18):1963-70. PubMed ID: 11555633
[TBL] [Abstract][Full Text] [Related]
38. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.
Rong C; Zhou R; Wan S; Su D; Wang SL; Hess J
Front Oncol; 2020; 10():592501. PubMed ID: 33585209
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.
Wang KK; Yang Z; Sarkis G; Torres I; Raghavan V
Expert Opin Ther Targets; 2017 Jun; 21(6):627-638. PubMed ID: 28434268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
